HSA 535 Week 7 Discussion Utilizing Cohort Study Designs to Track CVD
"Utilizing Cohort Study Designs to Track CVD"Â Â Please respond to the following:
·        From the first e-Activity, evaluate the efficacy of the steps in preventing cardiovascular disease (CVD) in your home state, and recommend at least five (5) steps to prevent CVD in your home state.
·        From the first e-Activity, analyze the information on CVD to determine some important steps to take when utilizing cohort study design to follow how diseases develop over time.
"Tracking Vaccine Preventable Diseases"Â Â Please respond to the following:
·        From the second e-Activity, analyze your home state’s position on vaccine-preventable diseases. Based on your analysis, give your opinion on whether or not you agree with your home state’s position. Explain your rationale.
·        From the case study and third e-Activity, suggest at least three (3) viable ways to utilize cohort study data to track and report on HPV.
Answers
Status NEW
Posted 24 Sep 2019 04:09 AM
My Price 5.00
HSA----------- 53-----------5 W-----------eek----------- 7 -----------Dis-----------cus-----------sio-----------n U-----------til-----------izi-----------ng -----------Coh-----------ort----------- St-----------udy----------- De-----------sig-----------ns -----------to -----------Tra-----------ck -----------CVD-----------
Attachments
file 1569299646-HSA 535 Week 7 Discussion.docx preview (725 words )
H-----------SA -----------535----------- We-----------ek -----------7 D-----------isc-----------uss-----------ion----------- &-----------quo-----------t;U-----------til-----------izi-----------ng -----------Coh-----------ort----------- St-----------udy----------- De-----------sig-----------ns -----------to -----------Tra-----------ck -----------CVD-----------&qu-----------ot;-----------Â Â----------- Pl-----------eas-----------e r-----------esp-----------ond----------- to----------- th-----------e f-----------oll-----------owi-----------ng:----------- F-----------rom----------- th-----------e f-----------irs-----------t e------------Ac-----------tiv-----------ity-----------, e-----------val-----------uat-----------e t-----------he -----------eff-----------ica-----------cy -----------of -----------the----------- st-----------eps----------- in----------- pr-----------eve-----------nti-----------ng -----------car-----------dio-----------vas-----------cul-----------ar -----------dis-----------eas-----------e (-----------CVD-----------) i-----------n y-----------our----------- ho-----------me -----------sta-----------te,----------- an-----------d r-----------eco-----------mme-----------nd -----------at -----------lea-----------st -----------fiv-----------e (-----------5) -----------ste-----------ps -----------to -----------pre-----------ven-----------t C-----------VD -----------in -----------you-----------r h-----------ome----------- st-----------ate-----------. -----------Fro-----------m t-----------he -----------fir-----------st -----------e-A-----------cti-----------vit-----------y, -----------ana-----------lyz-----------e t-----------he -----------inf-----------orm-----------ati-----------on -----------on -----------CVD----------- to----------- de-----------ter-----------min-----------e s-----------ome----------- im-----------por-----------tan-----------t s-----------tep-----------s t-----------o t-----------ake----------- wh-----------en -----------uti-----------liz-----------ing-----------
Not Rated(0)